Leah Buletti

UF Health has successfully performed the first hepatic artery infusion, or HAI, pump procedure.

The first robotic-assisted nipple-sparing mastectomies have been successfully performed at UF Health by Lisa Spiguel, M.D.

Cancer patients who could benefit from participating in clinical trials may never hear about such opportunities. To overcome this silence, researchers are creating a new chapter for a training program that teaches physicians how to communicate with cancer patients about the value of controlled cancer studies.

Drs. Elias Sayour and Rowan Milner work with dog patients to develop treatments that may one day heal humans with brain and bone tumors.

A long-term study of nearly 900 childhood cancer survivors found that the heart-protective drug dexrazoxane significantly reduced chemotherapy-related heart damage for years after treatment.

Sylvester patient Claudia Pereira uses her experience to raise awareness of sarcoma.

A multidisciplinary team at Sylvester set out to accomplish something that initially seemed impossible: completely remove Jada Anderson’s cancer while saving her leg.

A study from Sylvester Comprehensive Cancer Center reveals how a rare genetic mutation allows certain blood cancers to resist both BTK inhibitors and next-generation BTK degraders, providing new insights for developing more durable therapies for chronic lymphocytic leukemia and related malignancies.

Using an innovative technique, scientists discovered the first compound that effectively targets a protein that drives lung cancer.

Thomas George, M.D., FACP, FASCO, co-authored an AACI commentary on accelerating clinical trial activation.